Replies to post #163216 on Biotech Values

[oc631]

ABT-450 has not been tested much with interferon, although there will some data trickling out during the next few years from second-line studies in patients who failed on Incivek- or ABT-450-based regimens.

There was no mention of ABT-450 being tested with interferon during ENTA's latest presentation. Considering the deal with ABT was signed in 2006 I find this quite surprising.